{"title": "SYMPOSIA NONINVASIVE CARDIAC DIAGNOSIS I NONINVASIVE CARDIAC DIAGNOSIS 11 INFECTIOUS LUNG DISEASES ADVANCES IN HEMATOLOGY CUTANEOUS SIGNS OF SYSTEMIC DISEASES INFLAMMATORY BOWEL DISEASE ACUTE MEDICAL ILLNESS BODY FLUID AND ELECTROLYTE DISORDERS OBSTRUCTIVE LUNG DISEASES PROSTAGLANDINS CLINICAL ALLERGY GASTROINTESTINAL MOTILITY DISORDERS ANTIMICROBIAL THERAPY LIPID DISORDERS INTESTINAL INFECTIONS TREATMENT OF SKIN DISEASES CLINICAL PHARMACOLOGY OF SYMPTOM CONTROL DIABETES MELLITUS", "body": "Appendix, ulcerations, due to Yersinia infection, 1982 : May, 644 Arachidonic acid, metabolism, in plateletvessel wall interactions, 1981 : July, 855-880 in prostaglandin synthesis, 1981 716-720 metabolites, as mediators of hypersensitivity and inflammation, 1981: July, 809-828 Arrhythmia(s). See also specific disorders.\n\ncardiac, chronic airflow obstruction : May, 554 Arterial disease, extracranial, 1980 : March, 292-299 Arteriosclerosis, 1980 : July, 750 Arteritis, temporal, 1982 in the elderly, 1982 Arthralgia, in sarcoidosis, 1980 : Sept., 857 Arthritis, acute, 1981 : Jan., 177-188 digital, in psoriasis, 1982 : July, 773-774 . in sarcoidosis, 1980 in the elderly, 1982: Sept., 1047-1052 rheumatoid. See Rheumatoid arthritis. Ascariasis, drug therapy for, 1982 : May, 724-729 Ascorbic acid, iron metabolism and, 1980 : July, 633, 641 Aspergilloma, 1980 : May, 479-483 Aspergillosis, bronchopulmonary, allergic, 1981 : Sept., 1041 , 1061 cutaneous, 1980 : Sept., 961 in immunosuppressed host, 1980 : May, 540 Aspergillus lung disease, 1980 : May, 475-490 Aspiration pneumonias, 1980 Aspirin. See Acetylsalicylic acid. Asthma, 1981 : May, 456 airway hyperreactivity in, 1981 : Sept., 1024 -1026 aspergillus, 1980 : May, 477 assessment of, 1981 : Sept., 1033 -1036 bronchial reactivity and, 1981 : May, 475 bronchoconstriction of, 1981 : Sept., 1015 control of, 1981 : Sept., 1033 -1043 corticosteroids in, 1981 : Sept., 1059 drug therapy for, 1981 : May, 579-613 eosinophilia in, 1981 : Sept., 1058 immunotherapy for, 1981 : Sept., 990-993 mast cells in, 1981 : Sept., 1015 -1018 medications for, 1981 : Sept., 1038 -1040 neurogenic mechanisms in, 1981 : Sept., 1023 occupational, 1981 : May, 697-700 pathogenesis and pathophysiology of, cellular mechanisms in, 1981 : Sept., 1013 -1031 Astroviruses, 1982 Ataxia telangiectasia, 1981: Sept., 966 1401 Atherogenesis, arachidonic acid metabolism and, 1981 : July, 867-870 Atherogenic hyperlipoproteinemia, 1982 : March, 375-402 Atherosclerosis, heart sounds in, 1980 : Jan., 11 high density Iipoproteins and, 1982 : March, 331, 390 in diabetics, 1982 : Nov., 1347 -1348 in dogs, [3-very low density Iipoproteins and, 1982 : March, 393-395 in familial dysbetalipoproteinemia, 1982 : March, 450-451 in hyperlipidemia, 1982 : March, 331 low density Iipoproteins and, 1982 March, 395-396 LDL stimulation of cell growth and, 1982 : March, 397 macrophage accumulation hypothesis, 1982 : March, 396-397 pathogenetic models, 1982 : March, 377 plasma triglycerides and, 1982 : March, 519-522 Athlete's foot, 1982 : July, 878 Atopic disorders, immunotherapy of, 1981 Sept., 987-1012 adverse reactions to, 1981: Sept., 1002 selecting patients for, 1981: Sept., 998-1000 Atrial septal defect, heart sounds in, 1980:\n\nJan., 11,28 murmur of, 1980 : Jan., 19 Atypical pneumonias, 1980 : May, 507-527 Audiofrequency analysis, carotid, 1980 : March, 293 Auscultation, cardiac, 1980 Autoimmune disorders. See also specific disorders, as Myasthenia gravis. : Nov., 1215 -1217 Autoimmune hemolytic anemia, druginduced, 1980 : July, 600 Autoimmune thrombocytopenic purpura, 1980 : July, 762-768 Autosensitization, immunodeficiency and, 1981 : Sept., 960 Azathioprine, in inflammatory bowel disease, 1980 : Nov., 1127 Azlocillin, 1982 : Jan., 61-73 Azotemia, prerenal, 1981 : March, 414 BACILLUS Calmette-Guerin, prostaglandins and, 1981 : Jan., 206 Blastomycosis, 1980 : May, 455-457 South American, 1982 : May, 680-683 Bleeding, in acute leukemia, 1980 : July, 695 Blistering, vs. toxic epidermal necrolysis, 1980 Platelets. Blood glucose, as measure of diabetic control, 1982 : Nov., 1255 -1260 control, during pregnancy, fetal malformations and, 1982 : Nov., 1333 -1335 during surgery, 1982 : Nov., 1361 -1372 glycosylated hemoglobin and, 1982 : Nov., 1309 -1315 measurements, in diagnosis of diabetes, 1982 : Nov., 1199 -1200 meticulous control of, 1982 : Nov., 1317 -1324 during pregnancy, 1982 : Nov., 1329 -1333 self-monitoring of, 1982 : Nov., 1227 -1250 , 1259 -1260 , 1320 in patient education, 1982 : Nov., 1302 -1303 target levels, in diabetics, 1982 1228 platelets. See Platelets. Blood pressure, elevated. See Hypertension. Blood sampling, techniques, in diabetes, 1982: Nov., 256--259 Body weight, diabetes and, 1982 : Nov., 1196 Bone, infections, cephalosporins for, 1982 Jan., 186--188 lesions, in multiple myeloma, 1980 : July, 731 in sarcoidosis, 1980 mechanism of action, 1982: Jan., 135-136 pharmacokinetics, 1982 : Jan., 136 Colitis, pseudomembranous, 1982 : May, 655-664 ulcerative, symposium on, 1980 : Nov., 1021 -1198 Collagen, for acne, 1982 : July, 867-868 Collagen vascular disease, complement abnormalities in, 1980 : July, 653 Colon, adenocarcinoma of, 1980 : Sept., 888, 893 cathartic, 1981 : Nov., 1385 function during sleep, 1981 : Nov., 1372 -1373 ulcerations, due to Yersinia infection, 1982 : May, 644 Colonoscopy, in inflammatory bowel disease, 1980 : Nov., 1083 -1102 Coma, 1981 : Jan., 15-32 diabetic, 9181: Jan., 117-132 hyperosmolar nonketotic, in surgical patients, 1982 : Nov., 1369 --1370 Combination therapy, 1982 See also Antimicrobial therapy, combination. Complement, abnormalities of, 1980 : July, 653 in immune complex reactions, 1981 : Sept., 944 serum, in SLE, 1980 : Sept., 927 Complement system, disorders of, 1981 : Sept., 969--970 Concussion, 1981 : Jan., 20 Condylomata acuminata, 1982 : July, 812-814 Confusional state, acute, 1981 : Jan., 10, 15-32 in the terminally ill, 1982 : Sept., 1177 -1178 Congenital defects, fetal, diabetes and, 1982 : Nov., 1333 -1335 Congenital hypoplastic anemia, 1980 : July, 616 Congestive cardiomyopathies, 1980 : Jan., 34--37 echocardiography in, 1980 : Jan., 42-48 Congestive heart failure, 1980 : Jan., 47 radionuclide studies in, 1980 : Jan., 108 Conjunctiva, in sarcoidosis, 1980 : Sept., 856 Connective tissue disease, mixed, 1980 : Sept., 976 skin lesions with, 1980 : Sept., 839--843 Constipation, idiopathic, 1981 : Nov., 1386 in the terminally ill, 1982 : Sept., 1175 traumatic, 1981 : Nov., 1382 -1383 : Sept., 1135 -1139 with narcotics, 1982 : Sept., 1093 Contraction alkalosis, 1981 : March, 333 Convulsions, in the terminally ill, 1982 : Sept., 1178 \\ Coombs' and Cell reactions, 1980 : Sept., 983-896 Coombs' test, in hemolytic anemia, 1980 July , : Nov., 1337 -1341 Dementia, 1982 : Sept., 1143 -1160 drug-induced, in the elderly, 1982 : Sept., 1076 multi-infarct, 1982 : Sept., 1146 --1147 pathophysiology of, 1982 : Sept., 1150 -1151 : Sept., 1151 -1156 Denial, of illness, 1981 : Nov., 1347 -1348 causes of, 1982 : Nov., 1209 -1226 classification of, 1982 : Nov., 1191 -1197 concomitant disease and, 1982 : Nov., 1194 continuous insulin infusion in, 1982 : Nov., 1269 -1283 control of, during surgery, 1982 : Nov., 1361 -1372 with insulin, 1982 : Nov., 1251 -1267 diagnosis of, 1982 : Nov., 1197 -1205 gestational, 1982 : Nov., 1194 -1195 , 1326 --1329 glycosylated hemoglobin and, 1982 : Nov., 1309 -1315 hyperlipidemia with, 1982 : Nov., 1347 -ljJ60 diet therapy for, 1982 : March, 503-504 hypertension with, 1982 : Nov., 1373 -1388 insulin requiring, multiple subcutaneous insulin injections in, 1982 : Nov., 1251 -1267 male sexual dysfunction in, 1982 : Nov., 1389 -1396 maturity onset of youth, 1982 : Nov., 1197 meticulous control of, 1982 : Nov., 1317 -1324 during pregnancy, 1982 : Nov., 1329 -1333 neuropathy of, 1981 : Jan., 195 patient education in, 1982 : Nov., 1293 -1307 pregnancy and, management of, 1982 : Nov., 1325 --1346 : July, 759-771 psychological aspects of, 1982 1285--1292 Diabetes mellitus (Continued) self-monitoring of blood glucose : Nov., 1227 -1250 symposium on, 1980 : Nov., 1191 -1396 Diabetic gastroparesis, 1981 : Nov., 1279 Diabetic ketoacidosis, 1981 : March, 326 Diabetic retinopathy, effect of pump therapy on, 1.982: Nov., 1279-1280 Dialysis, in acute tubular necrosis, 1981:\n\nJan., 160 peritoneal, in psoriasis, 1982 : May, 788 renal, pruritus in, 1982 : Sept., 1127 -1128 Diamond-Blackfan syndrome, 1980 : July, 616 Diarrhea, 1981 acute, altering intestinal microflora, 1982:\n\nMarch, 569-570 in the terminally ill, : Sept., 1175 in Yersinia enteritis, 1982 : May, 639-653 infectious, 1982 : May, 575-595 nocturnal, 1981 : Nov., 1372 -1373 potassium depletion with, 1981 : Sept., 1057 Fenoterol, 1981 : May, 585 Ferritin assay, 1980 : July, 635 Festooning, 1980 : Sept., 817 Fetus, heart rate monitoring in, 1982 : Nov., 1337 -1338 1411 lung maturity, maternal : Nov., 1335 -1337 risk, maternal diabetes and, 1982 : Nov., 1325 -1346 Fever, allergic, 1981 : Sept., 1095 in leukemia, 1980 Gastric-cholecystic imaging, 1981 : Nov., 1301 -1308 Gastric secretion, prostaglandins and, 1981 : July, 776--778 Gastroenteritis, Vibrio, 1982 : May, 665-673 viral, 1982 : May, 575-595 Gastroesophageal reflux, 1981 : Nov., 1195 -1222 , 1223 -1234 behavioral therapy, 1981 : Nov., 1401 specific therapy, 1981 : Nov., 1225 -1231 Gastroesophageal scintigraphy, 1981 : Sept., 822 Hereditaryangioedema, 1980 : Sept., 872 Hereditary hemorrhagic telangiectasia, 1980 : Sept., 834 Hereditary spherocytosis, 1980 : July, 588-590 Heroin, for pain, 1982 : Sept., 1062 , 1093 Herpes simplex infection, 1982 : July, 807-810 Herpes zoster infection, 1982 : July, 810-812 prevention of, 1982 : Sept., 1109 -1110 therapy for, 1982 : Sept., 1105 -1118 Herpetic esophagitis, in immunocompromised patient, 1982 : March, 409-410 effect of obesitv, 1982 : March, 409-410 effect of physi~al activity, 1982 : March, 411-412 measurement, 1982 : March, 434-436 in clinical practice, 1982 : March, 437-438 pathologic states affecting, 1982 : March, 415-416 pharmacologic effects on, 1982 : March, 417-418 regulation, 1982 : March, 403-430 metabolism, 1982 : July, 834 Histoplasmosis, 1980 : May, 678-680 cutaneous, 1980 Hives. See Urticaria. HLA antigens, diabetes and, 1982 : Nov., 1195 -1196 , 1210 -1212 diabetic complications and, 1982 : Nov., 1217 -1218 Hodgkin's disease, 1980 : July, 654 prostaglandins and, 1981 : July, 833 Homeostasis, mechanisms of, 1981 : March, 284-286 Homocysteinuria, 1980 : July, 751 Honeymoon state, of insulin therapy, 1982 : Nov., 1239 Hookworm infection, 1982 : Sept., 996, 1002 Hyperbicarbonatemia, 1981 : March, 333 Hypercalcemia, 1981 : March, 386--389 in multiple myeloma, 1980 : July, 731 in sarcoidosis, 1980 : Sept., 856 of cancer, prostaglandins and, 1981 : March, 341-343 surgery for, 1982 : March, 546 treatment, 1982 : March, 355-358, 537-550 indications, 1982 : March, 537-539 in diabetics, 1982 : Nov., 1348 -1351 Hypercoagulation, thrombosis and, 1980 July, 743-759 Hypercortisolism. See Cushing's disease. Hypereosinophilic syndrome, 1981: Sept., 1066 Hyperglycemia. See also Diabetes mellitus. consequences of, 1982 : Nov., 1319 --1320 hypertonic syndromes and, 1981 : March, 281-284 Hyperkalemia, 1981 : March, 513-515 in children, diet therapy for, 1982 : March, 504 in diabetics, 1982 : Nov., 1347 -1360 of pregnancy, diet therapy for, 1982 : March, 504-505 primary, 1982 : March, 323-324 secondary, 1982 : March, 324-325 single diet concept for, 1982 : March, 499-502 therapeutic decision-making, 1982 March, 331-332 with diabetes, diet therapy for, 1982:\n\nMarch , 503-504 xanthomas in, 1982 : March, 330-331 Hyperlipoproteinemia, atherogenic, 1982 : March, 375-402 in diabetics, 1982 : Nov., 1348 -1351 Hypernatremia, hypertonic syndromes and, 1981 : March, 271-281 Hyperosmolality, 1981 : March, 272 Hyperparathyroidism, 1981 : March, 387 Hyperphosphatemia, 1981 : March, 391, 396--398 in chronic renal failure, 1981 : March, 442 Hyperpigmentation, 1980 : Sept., 813 Hyperplasia, nodular lymphoid, 1982 Hypersensitivity, arachidonic acid metabolites as mediators of, 1981: July, 809-828 immediate, mediators of, 1981: Sept., 951-955 immune mechanisms in, 1981 : Sept., 941-957 to penicillin, 1980 : May, 322 Hypertension, hyperlipidemia with, salt restriction for, 1982 : March, 513-515 in diabetics, 1982 : Nov, 1373 -1388 : July, 906 pulmonary, heart sounds in, 1980 : Jan., 11, 12 in obstructive lung disease, 1981 : May, 489--495, 554 systemic, heart sounds in, 1980 : Jan., 11, 13,30 systolic, in diabetics, 1982 : Nov., 1378 -1379 Hyperthyroidism, myopathy of, 1981 : Jan., 197 Hypertonicity, hypernatremia and, 1981 March, 271-281 potassium balance and, 1981: March, 365 treatment of, 1981: March, 286--288 Hypertrichosis, facial, 1980 : Sept., 813-815 Hypertriglyceridemia, 1982 : March, 519-535 evaluation of patient, 1982 : March, 527-529 in diabetics, 1982 : Nov., 1348 -1351 mechanisms, 1982 decreased clearance of triglyceride-rich Iipoproteins, 1982: March, 524-527 overproduction of apoprotein B, 1982:\n\nMarch, 523-525 overproduction of triglycerides, 1982:\n\nMarch, 522-523 secondary, 1982 : March, 527 treatment, 1982 : March, 529-531 Hypertrophic cardiomyopathy, 1980 : Jan., 38-42, 49-51 Hypertrophic subaortic stenosis, 1980 : Jan., 27,28 Hyperuricemia, 1980 : March, 299, 403-409 in multiple myeloma, 1980 : July, 732 Hyperviscosity syndrome, 1980 in multiple myeloma, 1980: July, 734 Hypoaldosteronism, 1981 : March, 376, 378, 434 Hypoalphalipoproteinemia, familial, 1982 : March, 478 Hypobetalipoproteinemia, familial, 1982 : March, 472-473 with chylomicronemia, 1982 : March, 474 Hypocalcemia, 1981 : March, 389-392 Hypochlorhydria, bacterial overgrowth and, 1982 : May, 563 Hypogammaglobulinemia, common variable acquired, 1982 : May, 745 X-linked infantiie congenital, 1982 : May, 745 Hypoglycemia, exercise-induced, 1982 : Nov., 1246 prevention of, 1982 July, 761-773 Immunity, humoral, defects in, 1981 : Sept., 961 normal, 1981 : Sept., 959 Immunization, viral, 1980 : May, 499 Immunocompromised host, fungal infections in, 1980 : Sept., 955-968 pneumonias in, viral, 1980 : May, 498-499 pulmonary infections in, 1980 873-893 immunodeficiency and, 1981 : Sept., 971 in leukemia, 1980 : July, 696 in multiple myeloma, 1980 : July, 731 in sickle cell anemia, 1980 : July, 779 mixed, combination therapy for, 1982 Jan., 17-18 obstructive lung disease and, 1981: May, 684 pulmonary. See Lung(s), infections and specific pathogens. respiratory, airway reactivity and, 1981:\n\nSept., 1045 -1053 venereal, treatment of, 1982 : July, 915-925 viral, diabetes and, 1982 : Nov., 1213 -1214 of skin, 1982 : July, 807-817 Infectious agents, in inflammatory bowel disease, 1980 : Nov, 1021 -1035 , 1040 -1045 Infestation, microfilarial, 1981 Inflammation, arachidonic acid metabolites as mediators of, 1981: July, 809-828 Inflammatory bowel disease, prostaglandins and, 1981; July, 781-782 symposium on, 1980 : Nov., 1021 -1198 Influenza, viral pneumonia after, 1980 : May, 494--496 Injury, accidental, benzodiazepines and, 1982 : Sept., 1021 Insect stings, anaphylactic reaction to, 1981 : Jan., 229 Insomnia, 1982 in the terminally ill, 1982: Sept., 1177 treatment for, 1982: Sept., 974-977 Instruments, for self-monitoring of blood glucose, 1982 : Nov., 1230 -1232 Insulin, adjustments in dose, 1982 : Nov., 1240 -1244 , 1258 -1260 continuous subcutaneous infusion, 1982 : Nov., 1254 -1257 by pump, 1982 : Nov., 1237 -1238 , 1269 -1283 psychological reactions to, 1982 : Nov., 1285 -1292 during pregnancy, 1982 : Nov., 1331 deficiency, in diabetes, 1982 : Nov., 1251 delivery, advances in, 1982 : Nov., 1320 management, during surgery, 1982 : Nov, 1361 -1372 metabolic effects of, 1982 : Nov., 1276 --1280 potassium balance and, 1981 : March, 366, 376 regimens, alternatives, 1982 1252-1261 in self-monitoring of blood glucose, 1982: Nov., 1235-1246 Insulin (Continued) secretion, in diabetes mellitus, 1982; Nov., 1317 Nov., -1319 Nov., prostaglandins and, 1981 July, 759-764 supplements, indications for, 1982 : Nov., 1244 -1246 , 1259 -1262 Insulin-dependent diabetes (IDD), 1982 : Nov., 1192 -1193 . See also Diabetes mellitus.\n\nInsulin infusion device(s), portable, 1982 : Nov., 1272 -1274 Insulitis, 1982 Nov., 1214 -1217 Interferon, 1982 : Jan., 236-237 Intertrigo, candidal, 1982 : July, 885-886 Intestinal infections, symposium on, 1982 : May, 557-762 Intestinal secretion, prostaglandins and, 1981 : July, 778 Intestine(s), function during sleep, 1981 : Nov., 1371 -1372 inflammatory disease (symposium), 1980 : Nov., 1021 -1198 skin signs of, 1980 : Sept., 941-954 migrating motor complex, 1981 : Nov., 1311 -1329 motility, disorders (symposium), 1981 : Nov., 1109 -1411 : July, 775 polyposis, skin disorders with, 1980 : Sept., 829-833 pseudo-obstruction syndromes, 1981 : Nov., 1331 -1358 Intoxication, drug, 1981 : Jan., 28-31 Intra-aortic counterpulsation, 1981 : Jan., 77-79 Intracardiac masses, on echocardiography, 1980 : March, 239-251 Intracranial tumors, 1981 : Jan., 21-25 Irritable bowel syndrome, 1981 : Nov., 1386 --1391 behavioral therapy, 1981 : Nov., 1402 -1404 Iron, absorption of, 1980 : July, 631 chelatable, 1980 : July, 635 deficiency of, 1980 : July, 636--638 metabolism of, disorders of, 1980 : July, 631-645 overload, 1980 : July, 639-641 porphyria cutanea tarda and, 1980 : Sept., 819 therapy, oral, intolerance to, 1980 : July, 637 transport of, 1980 : July, 632 Islet cell, destruction, in diabetic ketoacidosis, 1982 : Nov., 1214 -1217 Isoimmune neonatal purpura, 1980 : July, 769 Isolation and susceptibility testing, for pathogens, 1982 : Jan., 5-6 INDEX Isoniazid, adverse effects, 1982 : Jan., 214-217 antimicrobial spectrum, 1982 : Jan., 212-214 disposition of, in liver disease, 1982 : Jan., 263 for tuberculosis, 1982 : Jan., 209 pharmacokinetics, 1982 : March, 189 Thalassemia, 1980 : July, 784-800 Thalidomide, for pruritus, 1982 : Sept., 1125 -1126 Thallium-201 imaging, cardiac, 1980 : Jan., 83-89 in right ventricular enlargement, 1981 May, 500 Thallium-201 exercise scintigraphy, after PCTA, 1980 : March, 163-176 Thallium-201 scanning, in coronary artery disease, 1980 : March, 149-162 Theophylline, 1981 Sept., 1038 in cor pulmonale, 1981: May, 513 Therapeutic monitoring, of neuroleptics, 1982: Sept., 1000--1001 Thiabendazole, for parasitic infections, 1982: Jan., 251 Thiazosulfone, hemolytic anemias and, 1980:\n\nJuly, 585 Thoracic aorta, aneurysms of, 1981: Jan., 83-86 Thrill, 1980 : Jan., 15 Thrombocytopenia, as drug reaction, 1981 Sept., 1098 in immune thrombocytopenic : July, 761 Thromboembolic disease, in polycythemia, 1980 : July, 673 Thromboembolic disorders, prostaglandins and, 1981 : July, 870-874 Thrombogenic substances, 1980 : July, 747 Thromboplastin, 1980 : July, 748 Thrombosis, arachidonic acid metabolites and, 1981 : July, 867-870 deep venous, 1980 : March, 299-301 factors involved in, 1980 : July, 746 hypercoagulation and, 1980 : July, 743-759 on echocardiography, 1980 : March, 246-248 Thrombotic thrombocytopenic purpura, 1980 : July, 751 Thrush, oral, 1982 : July, 884 Thyroid gland, carcinoma of, 1980 : Sept., 837 D-Thyroxine, for hypercholesterolemia, 1982 : March, 544-545"}